GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

最近更新时间: 昨天, 9:09PM

75.95

1.88 (2.54%)

前收盘价格 74.07
收盘价格 73.83
成交量 3,180,093
平均成交量 (3个月) 5,141,293
市值 34,776,363,008
市盈率 (P/E TTM) 15.96
预期市盈率 (P/E Forward) 18.18
价格/销量 (P/S) 1.72
股市价格/股市净资产 (P/B) 3.69
52周波幅
57.65 (-24%) — 94.80 (24%)
利润日期 31 Jul 2025 - 14 Aug 2025
股息率 (DY TTM) 0.17%
营业毛利率 11.03%
营业利益率 (TTM) 14.78%
稀释每股收益 (EPS TTM) 4.76
季度收入增长率 (YOY) 2.70%
季度盈利增长率 (YOY) 50.80%
总债务/股东权益 (D/E MRQ) 97.51%
流动比率 (MRQ) 0.980
营业现金流 (OCF TTM) 1.78 B
杠杆自由现金流 (LFCF TTM) 1.58 B
资产报酬率 (ROA TTM) 5.87%
股东权益报酬率 (ROE TTM) 26.44%

市场趋势

短期 中期
行业 Health Information Services (US) 看跌 混合的
Health Information Services (全球的) 看跌 混合的
股票 GE HealthCare Technologies Inc. 看跌 看跌

AIStockmoo 评分

0.9
分析师共识 -0.5
内部交易活动 NA
价格波动 2.0
技术平均移动指标 0.0
技术振荡指标 2.0
平均 0.88

相关股票

股票 市值 DY P/E(TTM) P/B
GEHC 35 B 0.17% 15.96 3.69
TEM 10 B - - 36.25
HQY 9 B - 76.17 4.24
WAY 7 B - 316.62 2.20
RCM 6 B - - 2.14
PRVA 3 B - 191.25 4.07

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

部门 Healthcare
行业 Health Information Services
投资方式 Mid Core
内部持股比例 0.28%
机构持股比例 80.65%
52周波幅
57.65 (-24%) — 94.80 (24%)
目标价格波幅
73.00 (-3%) — 89.00 (17%)
89.00 (Wells Fargo, 17.18%) 购买
85.00 (11.92%)
73.00 (UBS, -3.88%) 保留
平均值 83.00 (9.28%)
总计 5 购买, 2 保留
平均价格@调整类型 67.81
公司 日期 目标价格 调整类型 价格@调整类型
Morgan Stanley 06 May 2025 78.00 (2.70%) 保留 67.09
UBS 05 May 2025 73.00 (-3.88%) 保留 69.37
Evercore ISI Group 01 May 2025 85.00 (11.92%) 购买 67.67
Goldman Sachs 01 May 2025 82.00 (7.97%) 购买 67.67
Wells Fargo 01 May 2025 89.00 (17.18%) 购买 67.67
Citigroup 30 Apr 2025 86.00 (13.23%) 购买 70.33
Piper Sandler 23 Apr 2025 88.00 (15.87%) 购买 64.89

该时间范围内无数据。

日期 类型 细节
01 Jul 2025 公告 GE HealthCare announces cash dividend for second quarter of 2025
24 Jun 2025 公告 FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
23 Jun 2025 公告 GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
21 Jun 2025 公告 GE HealthCare drives innovation in theranostics with latest technological advances
20 Jun 2025 公告 AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape
19 Jun 2025 公告 Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
12 Jun 2025 公告 GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions
02 Jun 2025 公告 PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
30 May 2025 公告 Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer
16 May 2025 公告 New Healthcare AI Models Could Reshape Everything From Burnout to Diagnostics
15 May 2025 公告 GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite
13 May 2025 公告 GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent
13 May 2025 公告 GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
12 May 2025 公告 GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system
05 May 2025 公告 AI Healthcare Boom Gains Speed as Regulators and Innovators Align
02 May 2025 公告 ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
30 Apr 2025 公告 GE HealthCare reports first quarter 2025 financial results
28 Apr 2025 公告 GE HealthCare management to present at upcoming investor conferences
24 Apr 2025 公告 GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
17 Apr 2025 公告 GE HealthCare to announce first quarter 2025 results on April 30, 2025
10 Apr 2025 公告 Cincinnati Children’s and GE HealthCare build collaborative research program to drive pediatric imaging innovation
09 Apr 2025 公告 GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions
显示更多
股息率 (DY TTM) 0.17%
2年平均股息收益率 0.13%
股息支付比率 2.63%
预计下次股息支付 Nov 2025
除息日 公告日期 支付日期 详情
25 Apr 2025 27 Mar 2025 15 May 2025 0.035 现金
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 现金
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 现金
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 现金
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 现金
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 现金
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 现金
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 现金
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 现金

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2025 0.070 2 0.09
2024 0.120 4 0.15
2023 0.090 3 0.12

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票